tomography (CT-thorax) showed a non-specific mediastinal mass. Whole-body [(18)F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG-PET/CT)] imaging revealed abnormality in the same topography (Fig 1A and B) . Mediastinal biopsy showed lymph node infiltrated by small-cell lung cancer (SCLC) (Fig C) .
tomography (CT-thorax) showed a non-specific mediastinal mass. Whole-body [(18)F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG-PET/CT)] imaging revealed abnormality in the same topography (Fig 1A and B) . Mediastinal biopsy showed lymph node infiltrated by small-cell lung cancer (SCLC) (Fig C) . A 56-year-old smoker woman presented with progressive gait disturbance, dysarthria, cerebellar ataxia, limb weakness, hyporreflexia, and weight loss. Electromyography was compatible with Lambert-Eaton myasthenic syndrome (LEMS). Serum anti-P/Q-type voltage-gated calcium channel antibody was detectable. Thoracic computed LEMS, especially the classical forms with positive antibody, should be extensively investigated to locate the tumor site 1, 2 . Additional tests such as FDG-PET are complementary tools of great value when conventional methods are inconclusive 1, 3 . Recommendation from European Federation of Neurological Societies is screen for SCLC by CT-thorax, followed by FDG-PET or integrated FDG-PET/CT 1 .
